142 related articles for article (PubMed ID: 36464738)
1. Reliability of Non-invasive Liver Fibrosis Assessment Tools Versus Biopsy in Pre- and Post-bariatric Surgery Patients with Non-alcoholic Fatty Liver Disease.
Schwenger KJP; Alali M; Ghorbani Y; Fischer SE; Jackson TD; Okrainec A; Allard JP
Obes Surg; 2023 Jan; 33(1):247-255. PubMed ID: 36464738
[TBL] [Abstract][Full Text] [Related]
2. Performance of Noninvasive Liver Fibrosis Tests in Morbidly Obese Patients with Nonalcoholic Fatty Liver Disease.
Alqahtani SA; Golabi P; Paik JM; Lam B; Moazez AH; Elariny HA; Goodman Z; Younossi ZM
Obes Surg; 2021 May; 31(5):2002-2010. PubMed ID: 33616848
[TBL] [Abstract][Full Text] [Related]
3. Noninvasive Liver Fibrosis Tests in Patients with Nonalcoholic Fatty Liver Disease: An External Validation Cohort.
Polyzos SA; Slavakis A; Koumerkeridis G; Katsinelos P; Kountouras J
Horm Metab Res; 2019 Feb; 51(2):134-140. PubMed ID: 30273934
[TBL] [Abstract][Full Text] [Related]
4. FIB-4, APRI, and AST/ALT ratio compared to FibroScan for the assessment of hepatic fibrosis in patients with non-alcoholic fatty liver disease in Bandar Abbas, Iran.
Amernia B; Moosavy SH; Banookh F; Zoghi G
BMC Gastroenterol; 2021 Dec; 21(1):453. PubMed ID: 34861841
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic Accuracy of Noninvasive Fibrosis Models to Detect Change in Fibrosis Stage.
Siddiqui MS; Yamada G; Vuppalanchi R; Van Natta M; Loomba R; Guy C; Brandman D; Tonascia J; Chalasani N; Neuschwander-Tetri B; Sanyal AJ;
Clin Gastroenterol Hepatol; 2019 Aug; 17(9):1877-1885.e5. PubMed ID: 30616027
[TBL] [Abstract][Full Text] [Related]
6. Impact of Obesity and Alanine Aminotransferase Levels on the Diagnostic Accuracy for Advanced Liver Fibrosis of Noninvasive Tools in Patients With Nonalcoholic Fatty Liver Disease.
Petta S; Wai-Sun Wong V; Bugianesi E; Fracanzani AL; Cammà C; Hiriart JB; Lai-Hung Wong G; Vergniol J; Wing-Hung Chan A; Giannetti A; Merrouche W; Lik-Yuen Chan H; Le-Bail B; Lombardi R; Guastella S; Craxì A; de Ledinghen V
Am J Gastroenterol; 2019 Jun; 114(6):916-928. PubMed ID: 31169533
[TBL] [Abstract][Full Text] [Related]
7. Performance of noninvasive scores for the diagnosis of advanced liver fibrosis in morbidly obese with nonalcoholic fatty liver disease.
de Carli MA; de Carli LA; Correa MB; Junqueira G; Tovo CV; Coral GP
Eur J Gastroenterol Hepatol; 2020 Mar; 32(3):420-425. PubMed ID: 31464779
[TBL] [Abstract][Full Text] [Related]
8. Liver biopsy-based validation, confirmation and comparison of the diagnostic performance of established and novel non-invasive steatotic liver disease indexes: Results from a large multi-center study.
Kouvari M; Valenzuela-Vallejo L; Guatibonza-Garcia V; Polyzos SA; Deng Y; Kokkorakis M; Agraz M; Mylonakis SC; Katsarou A; Verrastro O; Markakis G; Eslam M; Papatheodoridis G; George J; Mingrone G; Mantzoros CS
Metabolism; 2023 Oct; 147():155666. PubMed ID: 37527759
[TBL] [Abstract][Full Text] [Related]
9. Age as a Confounding Factor for the Accurate Non-Invasive Diagnosis of Advanced NAFLD Fibrosis.
McPherson S; Hardy T; Dufour JF; Petta S; Romero-Gomez M; Allison M; Oliveira CP; Francque S; Van Gaal L; Schattenberg JM; Tiniakos D; Burt A; Bugianesi E; Ratziu V; Day CP; Anstee QM
Am J Gastroenterol; 2017 May; 112(5):740-751. PubMed ID: 27725647
[TBL] [Abstract][Full Text] [Related]
10. Evolution of Non-alcoholic Fatty Liver Disease (NAFLD) Biomarkers in Response to Weight Loss 1 Year After Bariatric Surgery-a Post Hoc Analysis of the FibroTest Prospective Study.
Codjia T; Rebibo L; François A; Lagnel C; Huet E; Bekri S; Pattou F; Régimbeau JM; Schwarz L
Obes Surg; 2021 Aug; 31(8):3548-3556. PubMed ID: 33844174
[TBL] [Abstract][Full Text] [Related]
11. Modified thresholds for fibrosis risk scores in nonalcoholic fatty liver disease are necessary in the obese.
Ooi GJ; Burton PR; Doyle L; Wentworth JM; Bhathal PS; Sikaris K; Cowley MA; Roberts SK; Kemp W; O'Brien PE; Brown WA
Obes Surg; 2017 Jan; 27(1):115-125. PubMed ID: 27220852
[TBL] [Abstract][Full Text] [Related]
12. Noninvasive fibrosis tools in NAFLD: validation of APRI, BARD, FIB-4, NAFLD fibrosis score, and Hepamet fibrosis score in a Portuguese population.
Rigor J; Diegues A; Presa J; Barata P; Martins-Mendes D
Postgrad Med; 2022 May; 134(4):435-440. PubMed ID: 35332833
[TBL] [Abstract][Full Text] [Related]
13. Comparison between non-invasive methods and liver histology to stratify liver fibrosis in obese patients submitted to bariatric surgery.
Didoné Filho CN; Reginatto CJ; Ivantes CAP; Strobel R; Percicote AP; Petenusso M; Sobreira da Silva CJR; Benjamim CJR; Radominski RB
Obes Res Clin Pract; 2021; 15(2):152-156. PubMed ID: 33648885
[TBL] [Abstract][Full Text] [Related]
14. Significant fibrosis assessed by liver biopsy among Chinese bariatric surgery patients: A prospective cross-sectional study.
Huang Y; Dong S; Wang C; Dong Z; Chen W
Front Endocrinol (Lausanne); 2023; 14():1090598. PubMed ID: 36793287
[TBL] [Abstract][Full Text] [Related]
15. PERFORMACE OF TRIGLYCERIDE-GLUCOSE INDEX ON DIAGNOSIS AND STAGING OF NAFLD IN OBESE PATIENTS.
Smiderle CA; Coral GP; DE Carli LA; Mattos AA; Mattos AZ; Tovo CV
Arq Gastroenterol; 2021; 58(2):139-144. PubMed ID: 34231659
[TBL] [Abstract][Full Text] [Related]
16. Obesity Modifies the Performance of Fibrosis Biomarkers in Nonalcoholic Fatty Liver Disease.
Qadri S; Ahlholm N; Lønsmann I; Pellegrini P; Poikola A; Luukkonen PK; Porthan K; Juuti A; Sammalkorpi H; Penttilä AK; D'Ambrosio R; Soardo G; Leeming DJ; Karsdal M; Arola J; Kechagias S; Pelusi S; Ekstedt M; Valenti L; Hagström H; Yki-Järvinen H
J Clin Endocrinol Metab; 2022 Apr; 107(5):e2008-e2020. PubMed ID: 34971370
[TBL] [Abstract][Full Text] [Related]
17. Machine learning models are superior to noninvasive tests in identifying clinically significant stages of NAFLD and NAFLD-related cirrhosis.
Chang D; Truong E; Mena EA; Pacheco F; Wong M; Guindi M; Todo TT; Noureddin N; Ayoub W; Yang JD; Kim IK; Kohli A; Alkhouri N; Harrison S; Noureddin M
Hepatology; 2023 Feb; 77(2):546-557. PubMed ID: 35809234
[TBL] [Abstract][Full Text] [Related]
18. Assessment of liver fibrosis using non-invasive screening tools in individuals with diabetes mellitus and metabolic syndrome.
Shaji N; Singhai A; Joshi R
J Assoc Physicians India; 2022 Apr; 70(4):11-12. PubMed ID: 35443467
[TBL] [Abstract][Full Text] [Related]
19. Step layered combination of noninvasive fibrosis models improves diagnostic accuracy of advanced fibrosis in nonalcoholic fatty liver disease.
Yang M; Jiang L; Wang Y; Li X; Zou Z; Han T; Nan Y; Lu F; Zhao J
J Gastrointestin Liver Dis; 2019 Sep; 28(3):289-296. PubMed ID: 31517325
[TBL] [Abstract][Full Text] [Related]
20. The diagnostic utility of FIB-4 as a non-invasive tool for liver fibrosis scoring among NAFLD patients: a retrospective cross-sectional study.
Amer J; Alnees M; Salameh M; Daraghmeh A; Kabha A; AlHabil Y; Darwish A; Najajra D; Awwad M; Abu Hamdeh N; Abdoh Q
Eur Rev Med Pharmacol Sci; 2024 Apr; 28(8):3104-3111. PubMed ID: 38708469
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
